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TheEffectofPatentForamenOvaleClosurein
PatientsWithPlatypnea-OrthodeoxiaSyndrome
Mohammad Khalid Mojadidi,1MD, Rubine Gevorgyan,2MD, Nabil Noureddin,2MD,and
Jonathan M. Tobis,2†*MD,FACC
Background:  Platypnea-orthodeoxia  syndrome  is  a  rare  condition
characterizedbyhypoxemia in the upright position that is improved in the
supine position. Although several etiologies of platypnea-orthodeoxia exist,
it is frequently associated with right- to-left shunting of blood at the cardiac
or pulmonary level, usually via a patent foramen ovale (PFO). The aim of
this study was to evaluate the incidence ofplatypnea-orthodeoxia syndrome
in a select patient population with right-to-left shunting and to describe the
outcomes after  PFO  closure.Methods:  Patients  withplatypnea-orthodeoxia
were prospectively identified from a population of patients who had a PFO
and were referred to UCLA from 2001 to 2012. Those patients who elected
to have their PFO closed were assessed for the severity of their symptoms
and interval  SaO2changes.  The changes in  SaO2before and after  closure
were compared in the supine and upright position. Patients were classified
depending on the result of PFO closure as having “improved SaO2” or “no
change.”Results:  Of  683  patients  with  PFO-  associated  conditions,  17
(2.5%)  had  platypnea-orthodeoxia  and  elected  to  close  their
PFO.Theresultsin11of17patients(64.8%)wereclassifiedashaving“improvedSaO2”;  they
experienced  improvement  or  complete  resolution  of  their  dyspnea
andhypoxemia
(improvedS a O 2f r o m b a s e l i n e 5 . 2 64.7%w h e n r e c u m b e n t a n d 1 5
. 6 63.0%w h e n
upright,P50.03andP<0.0001,respectively).PatientswithnochangeafterPFOclosure
predominantlyhadapulmonaryetiologyfortheirhypoxia,withelevatedmeanpulmo-
narypressuresmeasuredbeforeclosure(51.4616.8mmHg,P50.06).Conclusion :PFOc
losuremayresolve  symptomatic  postural  dyspneaandhypoxemiaandis
aneffectivemethodfortreating  platypnea-orthodeoxia,butisnoteffectivewhen
theprimary
etiologyofthehypoxemiaisduetoapulmonarycause.VC2015WileyPeriodicals,Inc.
Key words: patent foramen ovale; platypnea-orthodeoxia syndrome; right-to-left shunt
BACKGROUND
Platypnea-orthodeoxia syndrome is a rare
clinical  condition  characterized  by  dyspnea
and hypoxemia in the upright position that
improves  in  therecumbentposition.  By
definition, platypnea refers to dyspneathatis
relieved by  lying  down,  and  worsened by
standing   orsitting  upright;
orthodeoxiaisarterial hypoxemiathat
ismade  worseintheupright
positionandimproved  on
lyingdown[1,2].Theetiologyofthissyndromeisus
u-allyattributedtothepresenceofaright-to-left(R
to  L)shunt  throughapatent  foramen  ovale
(PFO)orsome-   timesanatrial  septal  defect
(ASD)or  afenestrated  ASDwithinteratrial
aneurysm [3–5].Theprevalence  of  platypnea-
orthodeoxia among patientswithR to Lshunts
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TABLE I. Patients with Platypnea-Orthodeoxia Stratified by Medical Condition at the Time of Referral
N Pulmonarycomorbidities N Cardiaccomorbidities
3 Chronic obstructive pulmonary disease, Pulmonary 
fibrosis
2 Pulmonic stenosis, S/p repair
4 Pulmonary hypertension, idiopathic or due to 
vasculitis
1 Aortic aneurysm with dissection
3 Hepato-pulmonary syndrome 2 Ebstein anomaly, S/p repair
1 S/p lung transplant with opportunistic infection 1 Idiopathic nonischemic 
cardiomyopathya
aThis patient had combined cardiac and pulmonary comorbidities (hepato-pulmonary syndrome).
isunknown.Areviewofcurrent literature reveals
that  platypnea-orthodeoxiaismainly
observedinpatientswithprominentR  to
Lshunting,
severepulmonarydisease,hepaticfailureoraco
mbinationofthese[2].
The  pathophysiology  of  platypnea-
orthodeoxiaiscomplex  and  is  not  yet
completely  explained.  Atthecore  of
platypnea-orthodeoxia  lies  a
severeventilation-perfusion  mismatch,  with
or without a R to Lshunt[6,7]. It is uncommon
for  an  isolated  pulmonarypa-thology  to
manifest as platypnea-orthodeoxia.  Patients
with  pulmonary  disease  usually  have
improved ventila- tion when they sit up, and
therefore, increase theiroxy-gen saturation in
the  upright  position.  However,  platypnea-
orthodeoxia has been described in patients
who  have  lung  pathology  predominantly
affectingthelower  lobes,  resulting  in  severe
bibasilar ventilation- perfusion mismatch[8].
The aim of this study was to evaluate the
incidence    of  platypnea-orthodeoxia
syndrome in a select patient population with
R to L shunting and to describetheoutcomes
after PFOc l o s u r e .
METHODS
The  studypopulation  consistedof
683patientsreferred  to  theInterventional
Cardiologyprogram  at
theUniversityofCalifornia,Los
Angelesbetween2001  and  2012  for
theassessmentof  conditions
associatedwithPFO,  includingcryptogenic
stroke,  migraines,  acephal-gicmigraines,
sleepapnea,decompression
illness,andplatypnea-orthodeoxia.
Patientswere  assessed  for  the  presence
ofplatypnea-orthodeoxia  withtheinclusion  cri-
teria ofdyspneaandhypoxemia(measured by a
pulse-  oximeter  placed  on  afinger)in
theupright position,which was improved in the
supineposition.Thosewithunderlyingpulmonary
diseaseunderwent  pulmonaryfunction  testing
to  assess  the  degree  ofpulmonarydis-  ease.
Thepatientswereassessedfor the presence of a
R  to  L  shunt  byperformingatransesophageal
echocardio-gram
(TEE)bubblestudy(PhillipsiCAI,  iE33xMA-  TRIX,
Andover  Massachusetts)  alone
orincombinationwithatranscranial  Doppler
(TCD)  bubble  study  (Spencer  Technologies,
Seattle, Washington).Thisprospective
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observational study was approved by the 
Institutional Review Board.
The  reason  for  referral  was  hypoxemia
inallpatients.  However,  the  preliminary
diagnosis   atthetime  of  referral  varied;  to
help with theanalysis,patients were grouped
asfollowed:
1.Those with concomitant pulmonary 
pathologyinadditiontoPFOatthetimeofre
ferral.
2.Those with cardiac comorbidity (structural
cardiac anomaly in addition toPFO).
3.Those with a combination of pulmonary 
diseaseandcardiac anomaly (TableI ) .
Those  patients  with  platypnea-
orthodeoxia  andPFOunderwent
percutaneous  PFO  closure.  The  PFOmor-
phology was evaluated prior to the closure
procedure  using  TEE.  Whenever  the  PFO
appeared  to  be  larger  than  10  mm  by
ultrasound  imaging,  PFO
sizingwasperformed using a sizing balloon at
the time of closure. Postclosure assessment
consisted of clinical evaluation and TEE, or
TEE and TCD at 3 months,   exceptincases
where  the  patient  was  symptomatic,
whichwar-ranted  earlier  follow-up.  If  TCD
indicated a residual shunt  grade 3, then it
was repeated at 3 monthinter-vals up to 1
year oruntil complete resolutionof  the shunt,
asevidencedby anegativeTCD(grade0–2).
The level of dyspnea and hypoxemia was
reassessed  during  follow  up  and  patients
were classified into two groups:
“Improvedoxygen  saturation(SaO2)”:
SaO2improvedto>93%  atrestin  thesupine
and  sittingposition;  supplemental
oxygennolonger  required
whilesupine,noorlimitedoxygenrequiredwhe
nupright.
“No  change”:  Dyspnea  and  hypoxemia
may  have  improved,  but  saturation
remained<93% and the patient remained
symptomatic  requiring  supplemen-  tal
oxygen when supine and upright.
STATISTICAL ANALYSIS
Continuous  variables  were  expressed  as
meanval-ues±standard  deviation.  Nominal
anddichotomous
•
•
<Patent Foramen Ovale Closure in Platypnea-
Orthodeoxia
±
70
3
Fig. 1. Left-Fluorographic image of a measuring balloon placed across a sigmoid-
shaped, long PFO canal consistent with a large ostium secundum defect with
stretched walls. Right- fluoroscopic image of a measuring balloon placed across
the conventional PFO of a similar size. Both patients had their PFOs closed with a
Helex 30 mm device.
variables  were  expressed  as
frequencypercentage.SPSS  version  20.0
statistical  software  was  used  forthestudy
analysis (IBM Corporation, Armonk NY).Analy-
sis of variance and Fisher’s exact test were
usedforcomparison among the study groups;
paired wasusedf o r  c o m p a r i s o n  w i t h i n
t h e  s t u d y  g r o u p s .  A p-level
0.05 was used to determine significance.
RESULTS
Study Population
Of the 683 patients referred for evaluation
ofPFOrelated conditions,  23 patients  (3.4%)
were diagnosed with platypnea-orthodeoxia.
Of the 23, 18  (78.3%)  were found to have R
to  L   shunting   through   aPFOand  had  it
closed percutaneously. The other 5 patients
had primary liver or pulmonary disease with
platypnea and orthodeoxia but did not have
a PFO presentasdetermined by TCD or TEE.
One  patient  was  losttofollow-up,  and
therefore,  was  excluded  from
thefinalanalysis.  The  clinical  descriptors  of
the  17 patients  whose data  were analyzed
are presented in theSup-porting Information
Table.  The mean age at  thetimeof referral
was 62.6 13.8, and 59%wer e  fe ma le .
The  primary  pathology  was  a  pulmonary
condition  (i.e.,  COPD,  idiopathic  pulmonary
hypertension)  in10patients,  a  cardiac
etiology  existing  in  addition  tothePFO  (i.e.,
idiopathic  cardiomyopathy,  aortic  aneurysm,
adult  congenital  heart  disease  other  than
PFO)  in6patients,  and  both  a  cardiac  and
pulmonary condition    in 1 patient. In 4 of 17
patients, recent paralysis ofahemi-diaphragm,
either  iatrogenic  or  from  a  pathologi-  cal
process,  contributed  to  sudden  worsening
oftheconditionand,u l t imate ly , led tocons i
derat ionforPFO
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closure. In 3 of 17 patients (17.6%), balloon
sizingofthe  PFO  with  the  purpose  of
measuring  it  at  thetimeof  closure
demonstrated  a  long  tunnel  (Fig.  1).
In2cases,  PFO  closure  was  used  as  a
palliative  procedure    to  improve  the
patients’  quality  of  life  by
attemptingtoincreaseSaO2priortoalungorc
ardiactransplant.
PFO Parameters and Follow-up
Based  on  TEE  assessment,  the  mean
length of the PFO was 9.0 5.3 mm, with a
mean height
9.8 3.3 mm. An atrial septal aneurysm was
foundin3patients,and1hadaprominentE
ustachianvalve.
Prior to PFO closure, the mean TCD grade
atrestwas 3.7 0.8 and on release of Valsalva
was  4.3  0.9.  Initial  follow-up  was  2.1  1.7
months  after  theindexprocedure,  with  the
final  follow-up  on  surviving   patients
performed  at  11.4     3.4  months.  At
thattime,4 of 17 (23.5%) patients had mild
to  moderate  residual   R  to  L  shunting
demonstrated on TEE or TCD,withthe mean
Spencer  grade  of  2.5    2  at  rest  and
3.70.9onValsalva.
PFO Closure and Outcome
Thecomparison  among  patients
groupedbyoutcomeispresentedinTableII.
Thegroupswere  notstatistically
differentintermsof
age,bodymassindex,PFOanat-omy,orthe
typeofdeviceused  for
PFOclosure.Thosepatientswhoexperiencedani
mprovementoraresolutionoftheir
symptoms(“improvedSaO2”group)primarilyha
dacardiac  diagnosis;
thosewithnochangeinsymp-  toms  and/or
residual hypoxemiahadapulmonarydiag-nosis.
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TABLE II. Comparison of Patients Who Improved Versus Had No Change in Symptoms After Patent Foramen 
Ovale Closure
Improved Nochange
Variable Mean±SD, orN(%) Mean±SD, 
orN(%)
P-value
Totalpatients 11(100%) 6(100%) –
Age 59.0±12.9 69.3±14 0.1
Reasonforreferral Pulmonarycomorbidities 5(45.4%) 5(83.3%) 0.3
Cardiaccomorbidities 6(54.6%) 0(0%) 0.0427
Both 0(0%) 1(16.7%) 1
BMI(kg/m2) 30.1±5.8 29.1±7.6 0.8
PFO canal height oncath(mm) 9.3±3.0 11.5±4.9 0.3
Presence of atrials e p t a l aneurysm 1(9%) 2(33.3%) 0.5
Device Amplatzer 6(54.6%) 5(83.3%) 0.3
Helex 3(27.3%) 1(16.7%) 1
CardioSeal 1(9%) 0(0%) 1
Roboticsurgery 1(9%) 0(0%) 1
Presence  ofresidualshunt 2(18.2%) 2(33.3%) 0.6
FEV1  (%ofpredicted) 80.7±4.1 77.9±26.3 0.7
FVC  (%ofpredicted) 69.3±30.7 91.9±19.3 0.1
FEV1/FVC(%) 72.5±21.2 73.9±21.7 0.9
TV  (%ofpredicted) 81.3±6.5 99.5±4.9
<0.0001
TLC  (%ofpredicted) 107±18.1 92.5±0.7 0.0724
Mean pulmonary pressure (mmHg,precath) 28.1±10.3 51.4±16.8 0.0028
SaO2  supine(%,preprocedure) 90.5±6.9 83.2±5.4 0.0411
SaO2 upright(%,preprocedure) 76.3±5.2 76±6.9 0.9
SaO2 supine(%,postprocedure) 95.7±2.1 87.2±3.5
<0.0001
SaO2 upright(%,postprocedure) 91.7±7.8 78.5±4.9 0.002
TABLE III. Comparison of Oxygen Saturation Before and After PFO Closure in the Supine and Upright Position in 
Patients with Platypnea-Orthodeoxia
SaO2supine(%) SaO2upright(%)
Group Preclosure Postclosure P-value Preclosure Postclosure P-
value Improved 90.5±6.9 95.7±2.1 0.03 76.3±5.2 91.7±7.8
<0.0001
(N¼11)
Nochange 83.2±5.4 87.2±3.5 0.2 76.0±6.9 78.5±4.9 0.4
( N  ¼  6)                                                                                                                                                                                             
Lung  function  as  assessed  by  pulmonary
function  testing  (PFT),  in  those  with  no
symptom  changeafterPFO  closure,  was
similar  to  the  rest  of  the  studypopu-lation.
However,  their  mean  pulmonary
pressuresweresignificantly    higher
compared   with   the   otherstudy
group (p<0.05). Of the 4 patients with PFO
receiving bosentan or sildenafil treatment for
their  pulmonary
hypertension,3experiencednochangeins
ymptomsor
SaO2after  PFO  closure,  and  1  experienced
complete resolution of playpnea-orthodeoxia.
Ofthe  17patientswithplatypnea-orthodeoxia,
11(65%)experienceda“positive  change”
afterPFOclo-   sure,with  the
SaO2improvingto>93%   inthe   supine
andsitting  position.  These  patientsnolonger
required  supplementaloxygen  while
supineandrequiredeitherno
orverylimited  oxygenuse  whenupright
(TableII).Ofthe  11patientswho
wereinthe“improved  SaO2”   group,6(54%)
hadcomplete resolutionoftheirsymptoms.
Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.
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Of  the  17  patients,  6  (35.3%)  had  no
change  in  the  severity  of  their  symptoms
after closing  theirPFO.One patient had an
initial exacerbation of hypoxemia due to the
presence of  a significant residual R  to  L
shunt following use of a Helex device.  One
month   after  the  index  procedure,  this
patient  had  a  second  closure  procedure
using  an  Amplatzer   ASD   device   with
reduction  of  R  to  L  shunting  and
improvementindyspnea and hypoxemia[ 9 ] .
TableIIIpresentsthe  data  on  the
SaO2ofpatientsbefore  and  after  PFO
closure.FollowingPFOclosure,thepatientsfrom
the  “improved  SaO2”  group  experi-
encedanincreaseinthemeansupineSaO2by
5.2 4.7%, (p0.03).Similarly,the mean SaO2in
theupright position improvedby 15.6   3.0%
(p<0.0001).Of  the  11  patients,  6
nolongerrequired  use  of  supple-  mental
oxygen,  and  5required  limitedoxygen  only
whenuprightandduringphysicalexertion.
In  contrast,  the  increase  in  mean
SaO2observed among patients from the “no
change”  group  wasnotsignificant;  all  6
patients continued to require supple- mental
oxygen after PFOclosure.
Due  tosignificant  comorbiditiespresent  in
several  of  the  patients,  percutaneous
PFOclosure,thoughsuccess-ful,didnotimprove
the  overall  outcome.Fourpatientsdied.  One
patient died 7 weeks after the procedure due
to  heart  failure  fromrapidly  progressing
idiopathiccar-
diomyopathy;anotherpatientdied  after
8monthsdue  to  anunresectable  pancreatic
cancer.The  third  patient  died  as  a  result
ofinvasive  aspergillosisin  asingletrans-
planted  lung  andesophagealcarcinoma;  the
fourth  patient  died  from  amassive
pulmonaryembol ism.
DISCUSSION
Platypena-orthodeoxia  is  a  complex
medical  condi-  tion  where  patients  often
present with  comorbidities  that alone, or in
combination  with  PFO,  may  be  responsible
for  severe  postural  desaturation.  R
toLshunting  through  an  interatrial  defect
(e.g., a  PFOoran atrial septal defect) is the
most  frequent  etiologyofplatypnea-
orthodeoxia [5,10]. The associationwithatrial
septal  aneurysm,  Chiari  network  or  a
persistent Eustachian valve accentuates the
degree of  shunting  and may also potentiate
a  paradoxical   embolism   through  the
interatrial  defect  [11–13].  Platypnea-
orthodeoxia  has  been  described  after  an
unsuccessful  ASD closure where the rim of
the  Amplatzerdevicewas found to be sitting
on  the  anterior  wall  of  the  infe-  rior  vena
cava.  The  incorrect  placement  of
theASDdevice  over  the  inferior  vena  cava
orifice  directedtheinferior  vena  caval  blood
into  the  left  atrium[14].Although  PFO  is
present  throughout  a  patient’slife-time,
platypnea-orthodeoxia  occurs  later  in
life.Theonset  of  symptoms is  usually  linked
to  another  cardiac   or  extracardiac  event
that  changes  the  configurationofthe
interatrial  septum,  thereby  significantly
increasing  the  degree  of  shunting.  Some
examples  of  theseeventsare
pneumonectomy  with  a  mediastinal   shift,
aortic  root elongation, aortic root aneurysm,
kyphosis,  unilat-  eral  paralysis  of  the
diaphragm,  and  a  localizedperi-cardial
effusion.  It  is  hypothesized  that
theseeventsmay cause rotation  of  the heart
with  stretching  oftheinteratrial  septum  and
opening of the PFO flap, provid- ing a greater
degree  of  deoxygenated  blood  toenterthe
left  atrium.  When  the  correction  of  the
concomitant pathology leading to platypnea-
orthodeoxia  is  notpos-sible  (e.g.,
kyphoscoliosis,  pneumonectomy,
aorticrootdilation),  PFO  closure  can  be  an
effective  waytor e s o l v e  o r t h o s t a t i c
d ys p ne a  and  h yp o x e mi a [15] .
The concept of a postural change affecting
the
RtoLs h u n t i s n o t n e w . A c o r r e l a t i o n b e t
we en t h e magni-
tude of R to L shunting with the position of
the body during TCD was described by Lao
et al  in 2007 [16].  The authors postulated
that this postural dependence is likely due
to  buoyancy  of  bubbles  and  the  anterior
superior  location  of  the  PFO,  and possibly
due to a larger opening of the PFO flap in
the  sitting  position.  Caputi  et  al.  in  2008
postulated that the higher Spencer grade on
TCD  may  be  due  to  an  increase  in
theamountof  shunted  blood  from  the
recumbent  tostanding  position,  possiblydue
tostretchingof  the  PFO[17].The  prevailing
theory  is  thatplatypnea-orthodeoxia
resultsfrom  a  positionalmodificationof  the
PFOanatomysuch that a change from supine
to theuprightposition pro- ducesstretchingof
theinteratrial  communication,lead-  ing  to
increaseddeoxygenatedblood flow from the
right  atriumthroughthe  defect  [10].
Thisphenomenonhas
beendemonstratedusing  TEE  and  TTEwith
patientsmoving  from  the  supine
tosittingpositionduringthe  study  or  using
atilt-table[18–20].
Dyspneaexacerbated in theuprightposition
mayalsobe  seen  inpatients  with  hepato-
pulmonarysyndrome   who  havemultiple
pulmonary  arterio-venousfistulae  secondary
to  liver  failure  [2,5,21].Hepato-pulmonary
syndrome  withsymptoms  ofplatypnea-
orthodeoxiais  often  associatedwith
ascitesand  hydrothorax  with  pleu-  ral
effusion.  In  these  patients,  the
supineposition
allowsanyintrathoraciceffusion  to  spread
diffuselyacrosstheposteriorthorax,whereasth
euprightposition   causes
thisfluidtoaccumulatein the lung bases. The
accumu-lated fluid prevents expansionof the
lungs  and  aggra-  vates  hypoxemia.  In
addition  to  thismechanism,hepato-
pulmonarysyndromeis  also  associated  with
diffusearteriovenous fistulaeinthe pulmonary
circulation.  The  deoxygenatedvenous  blood
shunts  directly  into  the  pul-  monary  veins
without  being  oxygenated  in  thealveoli.In
thesepatients, sittinguprightresultsin shifting
of  blood  to  the  dilatedpre-capillarybeds  of
the  lung  bases,  causing
increasedhypoxemicdyspnea  [22–25].  This
postural dyspnea isobservedin 5% ofcirrhotic
patients[25].  Other  pulmonarydisordersthat
have  beenassoci-atedwith  platypnea-
orthodeoxiainclude  chronic  obstruc-
tivepulmonary  disease
(COPD),pulmonaryembolism,upper
airwaytumorandacute respiratory distresssyn-
drome, oftenwithno evidence ofintracardiacR
to Lshunting[6,26].
In ourpatient population,PFOclosure resulted
in  complete  resolutionoforthostatic
dyspneaandhypoxe-miain6/17(35.3%)
patientswithplatypnea-
orthodeoxia,andsignificant
improvementinanother5/17
(29.4%)patientsforatotalof11/17  (64.7%)
patients   who  improved
followingPFOclosure.Theresolutionofsymptoms
and  theabsenceofresidualR  to
Lshuntingonfollow-
upTCDdemonstratethattranscutaneous  PFO
closuremaybenefitasubsetofpatientsbyprevent
ing
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deoxygenated venous blood from getting 
mixed with oxygenated systemic blood.
While  the  etiology  of  platypnea-
orthodeoxia isusu-ally attributed to a R to L
shunt [1–5,10], 6 of the23patients referred to
us  with  a  clinical  diagnosisofplatypnea-
orthodeoxia  did  not  have  a  R  to  L
shuntbynoninvasive  testing.  In  addition,
35.3%  of  our  patients  diagnosed  with
platypnea-orthodeoxia  did  not  experi-  ence
any  change  in  their  subjective
symptomsand/orhypoxemia  following  PFO
closure. Although itwouldbe ideal to rule out
other etiologies as  the  primary  cause of
the orthostatic dyspnea prior to PFO closure,
clinically  this  may  not  be  possible.  In
patientswhohave both a pulmonary shunt as
well as  a  cardiac  shunt, PFO closure may
be  necessary  as  a  therapeutic  trial  to
determine  if  the  primary  etiology  of  the
hypox-
emiaisduetointracardiacRtoLshunting.
Since  platypnea-orthodeoxia  is  a  rare
disorderandnot commonly seen by clinicians,
it is often misdiag- nosed [27]. In our study
there  were  4  patients  whohadsevere
platypnea-orthodeoxia  despite  having  a
grade3R to L shunt by TCD, which represents
a small amount of blood flow. It is possible
that  these  patientshavegreater  shunting
from the inferior vena  cava  andaTCD with
agitated  saline  injection  from  the
legmayhaveproducedahighershuntgrade[
28].
In  our  study,  half  of  the  patients  with
pulmonary  comorbidities
experiencedsignificant  improvementoftheir
symptoms afterPFOclosure,asdocumentedby
improved  oxygen  saturation
anddecreasedneedforsupplemental  oxygen.
The  anatomicparametersof the PFO(lengthof
thecanal,  presenceof  ASA)weresimilar
between  those  who
experiencedimprovementand those who did
not.  Those  who  did  notexperienceany
change   from   PFO   closure
weresignificantlyolder  (74.7    4.7  vs.  59.5
9.9,  p     0.015).  The  base-line  pulmonary
function  testsdid  notdiffersignifi-cantly
between  groups,  makingPFT  anunreliable
predictorofsuccessafter   PFO
closure.Therefore,PFOclosure
shouldbeconsideredforthesepatients,with
concomitant  pharmacological  therapy
withsilde-  nafil  or  bosentan  to  alleviate  any
reversiblecompo-nent  ofpulmonary
hypertension.Toanticipate  theeffect  of  PFO
closure  on  pulmonary  pressures,thepressure
change  may  be  measured  in  the
rightatriumorpulmonary
arteryaftertemporary occlusionofthePFO with
an  inflated  balloon  [29].  Our  study  demon-
strated  thatthe  twodescriptors   which
predicteda  poor outcome after PFO closure in
patientswithplatypnea-orthodeoxia  were  a)
the  presence  of  severeCOPDat
thetimeofreferral
associatedwithmarkedpulmonaryhypertensio
nand b) othersevere co-morbidities present at
the  time  of  the  procedure(suchashepato-
pulmonarysyndrome).
CONCLUSION
In  patients  with  platypnea-orthodeoxia
who havealarge  intracardiac  R to  L  shunt,
successful  closureoft h e  P F O  m a y
r e s o l v e  s y m p t o m a t i c
p o s t u r a l dyspneaand  profound
hypoxemia.  PFO  closure  is  not  effective
when the primary etiology of the hypoxemia
is duetoa pulmonarycause.
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